Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 8

Results: 11

Cover Image, Volume 43, Issue 6.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. i, doi. 10.1002/cac2.12477

By:

Ma, Zhimin;
Lv, Jun;
Zhu, Meng;
Yu, Canqing;
Ma, Hongxia;
Jin, Guangfu;
Guo, Yu;
Bian, Zheng;
Yang, Ling;
Chen, Yiping;
Chen, Zhengming;
Hu, Zhibin;
Li, Liming;
Shen, Hongbing

Publication type:

Article

The MonarchE trial: improving the clinical outcome in HR<sup>+</sup>/HER2<sup>−</sup> early breast cancer: recent results and next steps.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 938, doi. 10.1002/cac2.12466

By:

Bertucci, François;
Finetti, Pascal;
Mamessier, Emilie;
De Nonneville, Alexandre

Publication type:

Article

Lung cancer risk score for ever and never smokers in China.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 877, doi. 10.1002/cac2.12463

By:

Ma, Zhimin;
Lv, Jun;
Zhu, Meng;
Yu, Canqing;
Ma, Hongxia;
Jin, Guangfu;
Guo, Yu;
Bian, Zheng;
Yang, Ling;
Chen, Yiping;
Chen, Zhengming;
Hu, Zhibin;
Li, Liming;
Shen, Hongbing

Publication type:

Article

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 943, doi. 10.1002/cac2.12447

By:

Bertucci, François;
De Nonneville, Alexandre;
Finetti, Pascal;
Mamessier, Emilie

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2023, v. 43, n. 8, p. 861, doi. 10.1002/cac2.12305
Publication type:: Article

Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 896, doi. 10.1002/cac2.12462

By:

Shi, Qing;
He, Yang;
Yi, Hong‐Mei;
Mu, Rong‐Ji;
Jiang, Xu‐Feng;
Fu, Di;
Dong, Lei;
Qin, Wei;
Xu, Peng‐Peng;
Cheng, Shu;
Song, Qi;
Chen, Sai‐Juan;
Wang, Li;
Zhao, Wei‐Li

Publication type:

Article

Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 909, doi. 10.1002/cac2.12459

By:

Hu, Xingbin;
Ma, Zhenfeng;
Xu, Beibei;
Li, Shulong;
Yao, Zhiqi;
Liang, Bishan;
Wang, Jiao;
Liao, Wangjun;
Lin, Li;
Wang, Chunling;
Zheng, Siting;
Wu, Qijing;
Huang, Qiong;
Yu, Le;
Wang, Fenghua;
Shi, Min

Publication type:

Article

Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 951, doi. 10.1002/cac2.12449

By:

Kwok, Hoi‐Hin;
Li, Huiyu;
Yang, Jiashuang;
Deng, Junyang;
Lee, Nerissa Chui‐Mei;
Au, Timmy Wing‐Kuk;
Sit, Alva Ko‐Yung;
Hsin, Michael Kuan‐Yew;
Ma, Stephanie Kwai‐Yee;
Cheung, Lydia Wai‐Ting;
Girard, Luc;
Fujimoto, Junya;
Wistuba, Ignacio Ivan;
Gao, Boning;
Minna, John Dorrance;
Lam, David Chi‐Leung

Publication type:

Article

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 947, doi. 10.1002/cac2.12448

By:

Niedermaier, Tobias;
Alwers, Elizabeth;
Chen, Xuechen;
Heisser, Thomas;
Hoffmeister, Michael;
Brenner, Hermann

Publication type:

Article

Differential risk of 23 site‐specific incident cancers and cancer‐related mortality among patients with metabolic dysfunction‐associated fatty liver disease: a population‐based cohort study with 9.7 million Korean subjects.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 863, doi. 10.1002/cac2.12454

By:

Chung, Goh Eun;
Yu, Su Jong;
Yoo, Jeong‐Ju;
Cho, Yuri;
Lee, Kyu‐na;
Shin, Dong Wook;
Kim, Yoon Jun;
Yoon, Jung‐Hwan;
Han, Kyungdo;
Cho, Eun Ju

Publication type:

Article

Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure.

Published in:

Cancer Communications, 2023, v. 43, n. 8, p. 956, doi. 10.1002/cac2.12450

By:

Bhardwaj, Megha;
Schöttker, Ben;
Holleczek, Bernd;
Brenner, Hermann

Publication type:

Article